https://www.selleckchem.com/pr....oducts/liraglutide.h
The current prevalence of chronic obstructive pulmonary disease (COPD) in France is estimated to be 2.6 million and is predicted to increase to 2.8 million by 2025. Presently, there is a lack of data on COPD management within the private healthcare setting. The aim of this study was to investigate the management of COPD exacerbations by pulmonologists within private practices in France. A prospective, online, qualitative survey was distributed to private practice pulmonologists in France. The survey covered all aspects of COPD manag
Like
Comment
Share
